Artigo Revisado por pares

Experts Achieve Consensus on a Majority of Statements Regarding Platelet-Rich Plasma Treatments for Treatment of Musculoskeletal Pathology

2023; Elsevier BV; Volume: 40; Issue: 2 Linguagem: Inglês

10.1016/j.arthro.2023.08.020

ISSN

1526-3231

Autores

Eoghan T. Hurley, Seth L. Sherman, Daniel J. Stokes, Scott A. Rodeo, Shane A. Shapiro, Kenneth Mautner, Don Buford, Jason L. Dragoo, Bert R. Mandelbaum, Kenneth R. Zaslav, Brian J. Cole, Rachel M. Frank, Mukesh Ahuja, Adam W. Anz, Jorge Chahla, Constance R. Chu, Ramón Cugat, João Espregueira‐Mendes, Jack Farr, David C. Flanigan, Alberto Gobbi, Andreas H. Gomoll, Daniel A. Grande, Mederic M. Hall, Kay Horsch, Jason L. Koh, Elizaveta Kon, Christian Lattermann, Louis F. McIntyre, Iain R. Murray, George F. Muschler, Norimasa Nakamura, Surena Namdari, Nicolás S. Piuzzi, Daniël B.F. Saris, Nicholas A. Sgaglione, Kurt P. Spindler, John M. Tokish, Adam B. Yanke,

Tópico(s)

Genital Health and Disease

Resumo

To establish consensus statements on platelet-rich plasma (PRP) for the treatment of musculoskeletal pathologies.

Referência(s)